We are live on ! Find out more
AXNX

Axonics, Inc. Common Stock

Delisted

AXNX was delisted on the 14th of November, 2024.

236 hedge funds and large institutions have $2.83B invested in Axonics, Inc. Common Stock in 2023 Q1 according to their latest regulatory filings, with 28 funds opening new positions, 107 increasing their positions, 67 reducing their positions, and 25 closing their positions.

New
Increased
Maintained
Reduced
Closed

60% more repeat investments, than reductions

Existing positions increased: 107 | Existing positions reduced: 67

12% more first-time investments, than exits

New positions opened: 28 | Existing positions closed: 25

0% more funds holding

Funds holding: 235236 (+1)

9% less capital invested

Capital invested by funds: $3.12B → $2.83B (-$293M)

31% less call options, than puts

Call options by funds: $6.42M | Put options by funds: $9.34M

50% less funds holding in top 10

Funds holding in top 10: 21 (-1)

Holders
236
Holders Change
+1
Holders Change %
+0.43%
% of All Funds
3.76%
Holding in Top 10
1
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-50%
% of All Funds
0.02%
New
28
Increased
107
Reduced
67
Closed
25
Calls
$6.42M
Puts
$9.34M
Net Calls
-$2.92M
Net Calls Change
-$3.07M

AXNX Hedge Fund Activity: Q1 2023 in Review

236 of the 6,275 institutional investors tracked by Wall St. Rank reported a position in Axonics, Inc. Common Stock (AXNX) for Q1 2023, worth a combined $2.83B — down 9.4% from $3.12B a quarter earlier.

Buyers outnumbered sellers: 28 funds opened new AXNX positions and 25 closed out — a net gain of 3 holders — while 107 added to existing stakes and 67 trimmed.

The largest buyer was Point72 Asset Management, opening a new position worth an estimated $62.5M. The largest seller was Polar Capital Holdings, exiting entirely with an estimated $44.4M sold.

  • 236 institutional investors held Axonics, Inc. Common Stock (AXNX) as of Q1 2023, up from 235 in Q4 2022.
  • Funds reported $2.83B of Axonics, Inc. Common Stock stock for Q1 2023, down 9.4% quarter-over-quarter.
  • 28 funds opened new Axonics, Inc. Common Stock positions in Q1 2023 and 25 closed out, a net change of +3 holders.
  • The largest Axonics, Inc. Common Stock buyer in Q1 2023 was Point72 Asset Management, an estimated $62.5M added.
  • The largest Axonics, Inc. Common Stock seller in Q1 2023 was Polar Capital Holdings, an estimated $44.4M sold.

Based on aggregated 13F filings for Q1 2023.